Translational Pharmaceutics and the Benefits of Real-Time Adaptive Manufacturing

Many pharma companies are seeking new ways of making drug development more efficient and cost-effective through innovation, new technologies and process evolution. This has led to an increase in the outsourcing of development activities to contract research partners who focus solely on disciplines such as discovery chemistry, clinical testing, and formulation development and manufacturing.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

What the food supply chain can learn from the pharma industry.

Controlant

With the increase and complexity of the global supply chain, both the pharmaceutical cold chain and temperature-controlled shipping for the food and beverage industry have seen substantial growth over the last few years. It is no coincidence that the food industry is now beginning to look to the pharmaceutical supply chain for guidance on best practices, as the need for stricter standardization and controls has emerged.
Watch Now

Overcoming Manufacturing Challenges for Accelerated Development

catalent

The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed. These designations are given shortened timelines for product development, product assessment and commercial scale-up (typically between 3-5 years) and come with several development and manufacturing challenges. In this webinar, you will hear from industry experts on overcoming scale-up challenges and fit-for-purpose manufacturing strategies.
Watch Now

Utilizing NGS for Proteomics - Olink® to Accelerate Drug Discovery and Optimize Clinical Trials Outcome

The future of healthcare will change for the better by adding more tailored treatment options, where patients get the best medication related to their disease state and predisposition.
Watch Now

Terminal Sterilization or Aseptic Assembly? Consider all options for your Pharma product.

webcasts

Regulation is clear that, whenever possible, products intended to be sterile should be terminally sterilized in their final container. Only if terminal sterilization is not possible, filtration or aseptic assembly should be applied. This webinar will focus on elements to evaluate prior to selecting aseptic assembly for the manufacturing of sterile drug products.
Watch Now